title: A twelve month double-blind randomized study of the efficacy and immunogenicity of human and porcine insulins in non-insulin-dependent diabetics.
abstract: This study aims to compare the effectiveness and immunogenicity of semisynthetic human insulin (NOVO) and highly purified (monocomponent) porcine insulin over a 12 month period in 16 non-insulin-dependent diabetic subjects not previously exposed to insulin. Sixteen patients were randomly allocated for treatment with either human (n = 9) or monocomponent porcine (n = 7) insulin in a double-blind trial. Both groups were identical with respect to age, sex and measures of metabolic control. Significant insulin antibody was detected in seven of the nine patients (78%) 3 months after the commencement of human insulin therapy whereas it was detected in all patients (100%) in the group treated with monocomponent porcine insulin as early as 2 months after insulin therapy. Besides the delayed rise of insulin antibodies during the first 3 months of human insulin therapy, it tended to have a lower mean insulin antibody titer, though statistically insignificant, at the end of the study. No adverse reaction to either type of insulins was noted. It is concluded that both semisynthetic human and monocomponent porcine insulin were safe and effective. Although human insulin showed a slightly lower immunogenicity than monocomponent porcine insulin of the same formulation and purities, it was not non-immunogenic. Hence, there is no reason to treat all insulin-requiring diabetic subjects with human insulin except those who have developed insulin allergy or those at risk or with a history of allergy.
authors.affiliation: Department of Medicine, National Yang Ming Medical College, Taipei, R.O.C.
authors.forename: L T
authors.initials: LT
authors.lastname: HO
authors.forename: H C
authors.initials: HC
authors.lastname: Lam
authors.forename: M S
authors.initials: MS
authors.lastname: Wu
authors.forename: C F
authors.initials: CF
authors.lastname: Kwok
authors.forename: T S
authors.initials: TS
authors.lastname: Jap
authors.forename: K T
authors.initials: KT
authors.lastname: Tang
authors.forename: L M
authors.initials: LM
authors.lastname: Wang
authors.forename: Y F
authors.initials: YF
authors.lastname: Liu
mesh_terms: D000328:Adult; D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000276:immunology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D007330:Insulin Antibodies / Q000032:analysis; D008297:Male; D008875:Middle Aged; D013552:Swine
chemical_list: D007328:Insulin; D007330:Insulin Antibodies